Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN Mayo Clinic
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Year in review: UMSL continues building for a stronger future
Look back at some of UMSL Daily’s top stories from the past year, including the launch of the UMSL School of Engineering and the naming of the Ed G. Smith College of Business, along with continuing campus transformation.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN Mayo Clinic
LATEST NEWS
- Year in review: UMSL continues building for a stronger future
- UMSL’s newest graduates celebrate their degrees at commencement
- Eye on UMSL: Honored guests
- Worth the wait: Sarah Wirthlin earns degree in music education more than two decades after finishing high school
- UMSL Tritons weekly rewind
- Mechanical engineering grad Max Evets leverages internship experiences into full-time position in Ameren’s new gas generation group
- At Boeing, UMSL alum Eric’el Johnson helps open doors for other engineering students
- First-generation college graduate Alondra Mendez plans to pursue master’s in data analytics after earning bachelor’s in math
- Eye on UMSL: Lifting his voice
- UMSL Entrepreneurship and Innovation Center welcomes newest Anchor Accelerator cohort
